Wel­come to 'tis­sue ther­a­peu­tics’: Dave Lennon’s $110M new ven­ture will im­plant ‘hap­py cells’ that ‘sur­vive and thrive’

You’ve heard of cell ther­a­pies. You’ve cer­tain­ly heard of gene ther­a­pies. But have you heard of tis­sue ther­a­peu­tics?

Just in time for May flow­ers, a biotech two decades in the works — longer if you count the co-founders’ first aca­d­e­m­ic en­coun­ters as grad stu­dent peers in the mid-1990s — has sprung from the shad­ows of Cam­bridge, MA to in­tro­duce the world to what it deems an “ex­cit­ing new pil­lar with­in the re­gen­er­a­tive med­i­cine field.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER